[VRDN] QoQ Quarter Result on 31-Dec-2017 [#Q4]

Stock
[VRDN] Viridian Therapeutics, Inc.
Announcement Date
14-Mar-2018
Financial Year
2017
Quarter
31-Dec-2017 [#Q4]
Profit Trend
QoQ- -9.46%
YoY- -14.65%
Quarter Report
VRDN's Result
VRDN's Financial Summary
View:
Show?
Quarter Result
30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 CAGR
Revenue 944 2,182 4,784 1,192 1,631 718 462 60.95%
PBT -9,011 -8,714 -4,661 -6,386 -5,834 -7,312 -6,980 18.54%
Tax 362 361 167 77 113 102 30 425.29%
NP -9,011 -8,714 -4,661 -6,386 -5,834 -7,312 -6,980 18.54%
Tax Rate - - - - - - - -
Total Cost 9,955 10,896 9,445 7,578 7,465 8,030 7,442 21.38%
Ratio Analysis
30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 CAGR
NP Margin -954.56 -399.36 -97.43 -535.74 -357.69 -1,018.38 -1,510.82 -26.34%
Per Share
30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 CAGR
EPS -4.40 -4.31 -2.64 -4.30 -4.06 -5.12 -9.06 -38.18%
EPS Diluted -4.40 -4.31 -2.64 -4.30 -4.06 -5.12 -9.06 -38.18%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.